Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Drug Repurposing against Phosphomannomutase for the Treatment of Cutaneous Leishmaniasis

Sabahat Yasmeen Sheikh, Waseem Ahmad Ansari, Firoj Hassan, et al.
Oriental Journal Of Chemistry 39 (1) 01 (2023)
https://doi.org/10.13005/ojc/390101

The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates

Philippe M. Loiseau, Kaluvu Balaraman, Gillian Barratt, et al.
Molecules 27 (7) 2313 (2022)
https://doi.org/10.3390/molecules27072313

Minor Impact of A258D Mutation on Biochemical and Enzymatic Properties of Leishmania infantum GDP-Mannose Pyrophosphorylase

Wei Mao, Noureddine Lazar, Herman van Tilbeurgh, Philippe M. Loiseau and Sébastien Pomel
Microorganisms 10 (2) 231 (2022)
https://doi.org/10.3390/microorganisms10020231

Alkyl-Resorcinol Derivatives as Inhibitors of GDP-Mannose Pyrophosphorylase with Antileishmanial Activities

Hélène Levaique, Olivier Pamlard, Cécile Apel, et al.
Molecules 26 (6) 1551 (2021)
https://doi.org/10.3390/molecules26061551

GDP-Mannose Pyrophosphorylase: A Biologically Validated Target for Drug Development Against Leishmaniasis

Sébastien Pomel, Wei Mao, Tâp Ha-Duong, Christian Cavé and Philippe M. Loiseau
Frontiers in Cellular and Infection Microbiology 9 (2019)
https://doi.org/10.3389/fcimb.2019.00186

In vitro and in silico Activity of Iridoids Against Leishmania amazonensis

Maria Helena Vendruscolo, Gustavo Machado das Neves, Luciano Porto Kagami, et al.
Current Drug Discovery Technologies 16 (2) 173 (2019)
https://doi.org/10.2174/1570163814666171002102058

Biochemical analysis of leishmanial and human GDP-Mannose Pyrophosphorylases and selection of inhibitors as new leads

Wei Mao, Pierre Daligaux, Noureddine Lazar, et al.
Scientific Reports 7 (1) (2017)
https://doi.org/10.1038/s41598-017-00848-8

Simple and efficient synthesis of $$5'$$ 5 ′ -aryl- $$5'$$ 5 ′ -deoxyguanosine analogs by azide-alkyne click reaction and their antileishmanial activities

Pierre Daligaux, Sébastien Pomel, Karine Leblanc, Philippe M. Loiseau and Christian Cavé
Molecular Diversity 20 (2) 507 (2016)
https://doi.org/10.1007/s11030-015-9652-9

Comparative study of structural models of Leishmania donovani and human GDP-mannose pyrophosphorylases

Pierre Daligaux, Guillaume Bernadat, Linh Tran, et al.
European Journal of Medicinal Chemistry 107 109 (2016)
https://doi.org/10.1016/j.ejmech.2015.10.037

In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes

Shahram Khademvatan, Neda Adibpour, Alborz Eskandari, et al.
Experimental Parasitology 135 (2) 208 (2013)
https://doi.org/10.1016/j.exppara.2013.07.004